Flunitrazepam: Long-acting drug
This medicinal product is characterized by a pronounced and prolonged effect. Its main task is to increase sleep depth.
Pharmacokinetic features:
- Onset of effect: the therapeutic effect develops 20–45 minutes after administration.
- Duration: persists for 6–8 hours.
- Metabolism and excretion: the drug is metabolized in the liver and excreted mainly by the kidneys. Meanwhile, the half-life ($t_{1/2}$) is a substantial 24–36 hours, which causes the substance to remain in the body for a long time.
The safety profile of flunitrazepam has much in common with nitrazepam, but requires strict adherence to contraindications. The drug must not be prescribed for liver and kidney impairment, myasthenia gravis, or during pregnancy and breastfeeding. Particular attention should be paid to drug interactions: flunitrazepam is strictly not recommended to be combined with monoamine oxidase (MAO) inhibitors.
Short-acting drugs: Triazolam
Unlike long-acting benzodiazepines, drugs in this group have a short half-life, which alters their clinical profile.
Triazolam is characterized by a half-life ($t_{1/2}$) of only 1–5 hours.
Key advantages:
- There is virtually no risk of cumulation (accumulation of the substance) upon repeated administration.
- The hangover effect is significantly less pronounced compared to long-acting benzodiazepines.
Midazolam: From insomnia to general anesthesia
Midazolam also belongs to short-acting benzodiazepines with a half-life ($t_{1/2}$) of 1 to 5 hours. Its use is strictly differentiated depending on the route of administration and the clinical objective.
Use as a hypnotic agent (per os): Oral administration is prescribed primarily to facilitate sleep onset. As with triazolam, there is no cumulation and only a negligible hangover effect.
Use in anesthetic practice:
- Premedication: used before surgical interventions (administered orally or intramuscularly).
- Induction of anesthesia: performed via intravenous administration.
Attention to risks: Parenteral (intravenous) use of midazolam is associated with a serious hazard. Rapid intravenous administration can cause severe respiratory depression, which may lead to complete respiratory arrest.
Briefly: answers to topical questions
What are the pharmacokinetic features of flunitrazepam?
Flunitrazepam is a long-acting drug. The onset of the effect occurs in 20–45 minutes, and the total duration is 6–8 hours. The drug increases sleep depth. Its metabolism takes place in the liver. Elimination is carried out by the kidneys with a half-life ($t_{1/2}$) of 24 to 36 hours.
What is the mechanism of action of hypnotic benzodiazepines at the molecular level?
Hypnotic benzodiazepines exert their effects through the GABAergic system. They stimulate allosteric benzodiazepine receptors linked to the $\gamma$-subunit of the $GABA_A$-receptor complex. This results in allosteric modulation of the complex, increased sensitivity to GABA, and an increased frequency of chloride channel opening. This leads to an enhanced influx of chloride ions into the neuron and membrane hyperpolarization.
Which drug is used as a specific antidote in case of a midazolam overdose?
Flumazenil is used as a specific antidote for benzodiazepine overdose, including midazolam. It is a competitive antagonist of benzodiazepine receptors. The drug effectively reverses the effects of agonists, restoring respiration and consciousness.
To remember the difference in half-life: Triazolam and Midazolam are "short" (1–5 hours, they come and go quickly), while Flunitrazepam is "long" (24–36 hours, like a long day).
Class and exam questions
What drugs are contraindicated in combination with flunitrazepam?
Flunitrazepam is not recommended to be combined with MAO inhibitors.
What is the main advantage of short-acting benzodiazepines?
They do not cause significant cumulation upon repeated administration and have a less pronounced "hangover effect" compared to long-acting analogues.
What is oral midazolam used for, and what are injections used for?
Orally (per os), midazolam is prescribed as a hypnotic to facilitate falling asleep. Parenterally (intramuscularly or intravenously), it is used in anesthesiology for premedication and induction of anesthesia.
What is the danger of intravenous administration of midazolam?
Especially with rapid intravenous administration, there is a high risk of respiratory depression up to complete respiratory arrest.
What else to study on this topic
- The mechanism of the "hangover effect" when taking long-acting benzodiazepines
- Comparative characteristics of the safety profile of flunitrazepam and nitrazepam
- Features of midazolam premedication: dosages and respiratory monitoring
- The effect of liver and kidney damage on the pharmacokinetics of flunitrazepam
- Reasons for absolute contraindications of benzodiazepines in myasthenia gravis
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Hypnotic benzodiazepines (Flunitrazepam, Triazolam, Midazolam)" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Used in Psychiatry and Neurology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.